Pulmonary hypertension life expectancy and prognosis can vary broadly, but have improved in the era of modern treatment.

Pulmonary hypertension (PH) can be challenging for healthcare professionals to diagnose because of its vague symptoms, such as fatigue and shortness of breath. These symptoms, which may be mild ...

In a widely expected decision, the Food and Drug Administration approved Merck’s Winrevair for injection, making it the first activin signaling inhibitor therapy for pulmonary arterial hypertension ...

Early initiation of macitentan and tadalafil therapy in PAH patients results in similar survival and hospitalization rates, regardless of diagnosis timing. Newly diagnosed PAH patients often present ...

Although more women than men have pulmonary arterial hypertension, several PAH medications are teratogenic, according to a ...

Pulmonary arterial hypertension (PAH) is a type of high blood pressure in the arteries in your lungs. It happens when these arteries become narrow or blocked, making it harder for blood to flow ...

With the FDA expected this week to approve a first-in-class treatment from Merck for pulmonary arterial hypertension (PAH), Johnson & Johnson has beaten its New Jersey rival to the punch with a nod ...

Please provide your email address to receive an email when new articles are posted on . The Kids MoD PAH Trial is recruiting pediatric patients with newly diagnosed PAH. Sildenafil plus bosentan vs.

People living with CTEPH face significant symptoms that affect daily life, even when receiving treatment, a real-world U.S.

Pulmonary arterial hypertension (PAH) is a type of high blood pressure in the arteries that go from your heart to your lungs. It happens when these arteries become narrow or blocked, making it harder ...

To assess how a patient with pulmonary arterial hypertension (PAH) is faring on therapy, look at the right heart, said Anjali Vaidya, MD, in a presentation at the Annual Meeting of the American ...